Heart Disease Trial, Recruiting (NCT05796739)

Heart Disease Trial, Recruiting NCT05796739 Sponsor: Samsung Medical Center Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05796739 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are at least 19 years of age
People who have no symptoms but have a high level of calcium buildup in the arteries of the heart, shown by a special scan score of 400 or higher (called an Agatston Score)

Who may not be able to join:

People who have had test results showing that part of their heart is not getting enough blood during physical activity or stress, recorded before joining the trial
People who have been found to have a major blockage (70% or more) in one of their heart arteries, confirmed by a heart imaging test before joining the trial
People who have previously had a procedure to open up or bypass blocked heart arteries
People who are pregnant or breastfeeding
People who have a serious non-heart-related health condition that means they are expected to live less than one year, or that may make it difficult to follow the trial's requirements (as assessed by the trial doctor)
People who are unwilling or unable to follow the procedures involved in this trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Seung-Hyuk Choi, MD, Samsung Medical Center

Phone: 82-2-3410-3419

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05796739

Sponsor: Samsung Medical Center

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: 82-2-3410-3419

More information: https://clinicaltrials.gov/study/NCT05796739

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are at least 19 years of age
People who have no symptoms but have a high level of calcium buildup in the arteries of the heart, shown by a special scan score of 400 or higher (called an Agatston Score)

Who may not be able to join:

People who have had test results showing that part of their heart is not getting enough blood during physical activity or stress, recorded before joining the trial
People who have been found to have a major blockage (70% or more) in one of their heart arteries, confirmed by a heart imaging test before joining the trial
People who have previously had a procedure to open up or bypass blocked heart arteries
People who are pregnant or breastfeeding
People who have a serious non-heart-related health condition that means they are expected to live less than one year, or that may make it difficult to follow the trial's requirements (as assessed by the trial doctor)
People who are unwilling or unable to follow the procedures involved in this trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Samsung Medical Center

Registry

ClinicalTrials.gov

Start date

3 July 2023

Est. completion

30 June 2029

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Occurrence of major adverse cardiovascular events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov